Subscribe
Sign in
Subscribe
Sign in
GlobalData
GlobalData

Media

The FT, Sky News, Bloomberg, WSJ, along with over 77 other leading press organisations worldwide quote our data and insight and consider us a trusted, independent source.

US structural heart occlusion market sees early 2025 growth amid trade uncertainty, says GlobalData

The US Structural Heart Occlusion (SHO) market posted a notable 39% year-over-year revenue increase in Q1 2025, amid heightened trade policy uncertainty following President Donald Trump’s re-election and the swift introduction of new tariff measures in early 2025, according to GlobalData, a leading data and analytics company. Trump’s new tariff regime includes a 10% global […]
Read more

Asia-Pacific card payments market to reach nearly $25 trillion in 2025, forecasts GlobalData

The Asia-Pacific (APAC) card payments market is expected to growth by 4.3% to reach $24.7 trillion in 2025 supported by growing preference for electronic payments. Strong growth in markets like China, South Korea, Japan, and Australia is complemented by rising adoption in emerging economies, supported by infrastructure improvements, regulatory initiatives, and expanding financial inclusion across […]
Read more

Sanofi and Regeneron AIM4 trial may redefine timing of biologic use in asthma care, says GlobalData

Sanofi and Regeneron Pharmaceuticals (Regeneron) have launched the Phase IIIb/IV AIM4 trial at the 2025 American Thoracic Society (ATS) International Conference to evaluate whether earlier initiation of dupilumab improves outcomes in patients with moderate-to-severe asthma compared to standard stepwise escalation with high-dose inhaled corticosteroids. The study reflects a growing shift toward personalized, biomarker-driven asthma management […]
Read more

MPTS 2025 celebrates largest edition ever with record visitor numbers, reveals MBI, a GlobalData company

The UK’s most powerful hub for the creative industries united for two days of engaged networking, passionate debate and exceptional insights into AI, the creator economy, production craft and more – helping attendees stay ahead-of-the-curve for the year ahead. London, United Kingdom, 21 May 2025 – After two exceptional days of conversation, collaboration and community, […]
Read more

US medical device companies show diverging paths on tariff strategy, says GlobalData

The Trump administration’s 2025 trade agenda is compelling US medical device companies to address escalating tariff pressures, especially those on imports from China. While some are making decisive shifts in their manufacturing strategies, others are conservatively absorbing short-term impacts and awaiting tariff stabilization. As such, firms must carefully evaluate the long-term risks of trade disruption […]
Read more

Mycobacterium tuberculosis tests market in Japan to grow at 4% CAGR through 2036, forecasts GlobalData

As one of the world’s deadliest infectious diseases, tuberculosis (TB) continues to pose a significant global health challenge, especially in low-resource settings, where the lack of timely, accurate, and accessible diagnostics hampers eradication efforts. Against this backdrop, the Mycobacterium tuberculosis tests market in Japan is projected to achieve substantial growth, with an anticipated compound annual […]
Read more

South Korea spent $222 billion on defense from 2021 to 2025, reveals GlobalData

The rising tensions with North Korea, coupled with China’s increasing assertiveness, have necessitated South Korea to bolster its military capabilities and readiness. These strategic enhancements include investments in advanced weapons systems, military preparedness, and fortification of cybersecurity infrastructure. In light of these developments, the country has allocated $222 billion for the period from 2021 to […]
Read more

Healthcare professionals recognize virtual care role in empowering patients, reveals GlobalData

As digital health technologies continue to evolve, healthcare professionals (HCPs) are increasingly recognizing the role of virtual care in empowering patients. Against this backdrop, a significant majority of HCPs believe trends like telemedicine and remote care have given patients more control over their health management, underscoring the growing importance of virtual care in modern healthcare, […]
Read more

Revolut’s EUR1 billion investment in France raises concerns over UK FinTech competitiveness, says GlobalData

Following the news that London-based FinTech giant Revolut Ltd plans to invest EUR1 billion in France and relocate its Western European headquarters to Paris; Harry Swain, Banking and Payments Analyst at GlobalData, a leading data and analytics company, offers his view: “Revolut’s shift towards a dual-headquarter model in Paris and Vilnius speaks volumes about the […]
Read more

Real-world data backs anti-IL-5 use in COPD with comorbid asthma, says GlobalData

Anti–IL-5 biologics, such as mepolizumab and benralizumab, have demonstrated significant efficacy in reducing moderate and severe exacerbations in patients with both asthma and chronic obstructive pulmonary disease (COPD), according to new real-world data presented at the 2025 American Thoracic Society (ATS) International Conference. These findings reinforce the therapeutic potential of eosinophil-targeting agents in patients with […]
Read more

Cautious investor sentiment pulls global deal activity down 5% YoY in first four months of 2025, finds GlobalData

Cautious investor sentiment has weighed heavily on the global deal landscape, with mergers and acquisitions, private equity, and venture financing activities collectively declining by approximately 5% year-on-year (YoY) during the first four months of 2025. Geopolitical uncertainty and macroeconomic headwinds have prompted dealmakers to adopt a more selective, risk-averse approach, leading to a slowdown across […]
Read more

US health insurance uptake faces uncertainty amid Trump’s policies, says GlobalData

Fewer than half of low-income individuals in the US have private health insurance*. Trump’s politics bring uncertainties to the pharmaceutical industry, which will likely translate into higher health insurance rates for consumers, potentially pricing out Americans with lower disposable income, while leaving others underinsured, according to GlobalData, a leading data and analytics company. According to […]
Read more

Tezepelumab’s trial results strengthen potential for biomarker-driven biologic therapies in COPD, says GlobalData

Tezepelumab, a thymic stromal lymphopoietin (TSLP) inhibitor developed by AstraZeneca and Amgen, demonstrated significant reductions in chronic obstructive pulmonary disease (COPD) exacerbations among eosinophilic subgroups, regardless of chronic bronchitis status, according to new post hoc findings presented at the 2025 American Thoracic Society (ATS) International Conference. These results further support the potential for biomarker-driven biologic […]
Read more
1 … 64 65 66 67 68 … 773